Insider trades

Steven F. Bellon, Chief Officer of Foghorn Therapeutics FHTX, has filed 0 purchases and 1 sale on the open market. The latest trade was on 01/30.

Steven F. Bellon

Chief Scientific Officer
First filing
23/01/30
Trades
5 trades
Buys / sales
0 / 1
12-month net buying
No record
Last trade
01/30

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan24/09/0924/09/1120,000 sh$9.50$190,000−16.4%